Opportunity to Further Educate the Industry on its Proprietary AST-Organosolv Process Technology and Contract R&D Services
MILTON, GA , April 16, 2018 (GLOBE NEWSWIRE) -- Meridian Waste Solutions, Inc. (NASDAQ: MRDN) (the “Company” and recently proposed announced name change to “Attis Industries, Inc.” or “Attis”), an integrated technology and innovations company, today announced that its subsidiary, Attis Innovations, will be attending and presenting at this year’s International Biomass Conference & Expo in Atlanta, GA on April 16-18. Attis Innovations will be conducting two different presentations, both of which will focus on its exclusively licensed AST-Organsolv Process Technology from American Science and Technology Corporation (“AST”).
The 11th Annual International Biomass Conference & Expo is one of the premier networking and educational conferences for the global biomass industry. The event attracts current and future producers of bioenergy, biobased products and biomass stakeholders interested in extracting new value from their biobased materials. The biomass market has seen tremendous growth over the last five years, and Attis Innovations feels strongly that its proprietary processing technology can bring new sources of revenue to a market needing further innovations to expand beyond its current state.
Attis Innovations will be presenting in two different tracks to further educate the biomass industry about its patented and patent pending process technologies as well as the contract R&D services available through its pilot-scale facility in Wausau, WI. Dr. Ali Manesh, an inventor of the AST-Organosolv process and founder of AST, will be moderating two separate sessions and Dr. Raghu Gurram and Jordan Thut will be presenting. Dr. Manesh has more than 30 years of experience in research, development, deployment, and manufacturing of various process technologies including alternative energy technologies. Dr. Manesh has authored eight US patents and is the foremost expert in the industry for Organosolv processing technology for biomass.
During its presentations, Attis Innovations will focus on the technical aspects of the AST-Organosolv process, the various high value, unique products produced and overall flexibility compared to traditional biomass processing technologies. Attis Innovations will also concentrate on promoting its ability to provide contract R&D services through its pilot-scale processing facility and laboratory in Wausau, WI. Attis Innovations’ facility in Wausau, WI has been in operation since 2003 and specializes in working with various types of lignocellulosic biomass for classification and conversion into its higher value constituents. The Wausau facility has worked with numerous universities, Fortune 500 companies, research institutes, and entrepreneurs to assess the strengths and weaknesses of new bio and chemical processes while lowering the financial risk related to pre-commercialization investments.
“We are very excited and honored to have the opportunity to participate in one of the biomass industries pillar events,” said Meridian Waste Solution/Attis Industries Chief Executive Officer, Jeff Cosman. “Participation in these events is a key component to further educating the industry on our innovative technology and contract R&D services capabilities. We believe strongly that our Organosolv process technology can drastically alter the biomass processing industry by opening up new opportunities for lower value sources of biomass to generate previously unthought of revenue.”
Mr. Cosman added, “The staff at our Wausau pilot and laboratory facility is second to none for Organosolv processing technology and laboratory services, and we are eager to showcase that talent through this highly regarded and attended conference.”
About Meridian Waste Solutions, Inc. / Attis Industries
Meridian Waste Solutions, Inc. (MRDN) is a company defined by our commitment to servicing our customers with unwavering respect, fairness and care. We are focused on finding and implementing solutions for the resource needs and challenges of our customers with a fundamental objective to seek rewarding solutions through technology and innovation. Our healthcare business centers on creating community-based synergies through collaborations and software solutions. Our innovation business (www.attisinnovations.com) strives to create value from recovered resources. For more information, visit www.mwsinc.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “should,” “would” or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. These statements are subject to certain risks, uncertainties, and assumptions, including, but not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies, the Company’s completion of the sale of its solid waste business; the ability of the Company to continue to meet the listing requirements of NASDAQ; the ability of the Company to execute on a business plan that permits the technologies and innovations businesses to provide sufficient growth, revenue, liquidity and cash flows for sustaining the Company’s go-forward business, and the risks identified and discussed under the caption “Risk Factors” in the Meridian Annual Report on Form 10-K for the fiscal year ended December 31, 2016, filed with the Securities and Exchange Commission (the “SEC”) on April 17, 2017 and amended on May 31, 2017 and the other documents Meridian files with the SEC from time to time. There will be events in the future, however, that Meridian is not able to predict accurately or control. Meridian’s actual results may differ materially from the expectations that Meridian describes in its forward-looking statements. Factors or events that could cause Meridian’s actual results to materially differ may emerge from time to time, and it is not possible for Meridian to accurately predict all of them. Any forward-looking statement made by Meridian in this press release speaks only as of the date on which Meridian makes it. Meridian undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Media and Investors Contact: Hayden IR firstname.lastname@example.org (917) 658-7878